SGO 2022 Conference Coverage on VuMedi

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

SGO 2022 Conference Coverage on VuMedi

Videos

SGO 2022 Phase II Trial of Maintenance Niraparib in Stage III/IV or Platinum-Sensitive Recurrent Uterine Serous Carcinoma

By SGO 2022 Conference Coverage on VuMedi FEATURING Marina Frimer

203 views

April 7, 2022

Comments 0

Videos

SGO 2022 Effectiveness & Safety of Neoadjuvant Niraparib in Advanced…

SGO 2022 Conference Coverage on VuMedi

Q. Gao

30 views

SGO 2022 on Health Care Services Burden in Ovarian Cancer Patients R…

SGO 2022 Conference Coverage on VuMedi

D. Chase

188 views

SGO 2022 on Pembrolizumab for Persistent, Recurrent, or Metastatic C…

SGO 2022 Conference Coverage on VuMedi

D. Barrington

239 views

SGO 2022 Phase II Trial of Maintenance Niraparib in Stage III/IV or …

SGO 2022 Conference Coverage on VuMedi

M. Frimer

203 views

SGO 2022 Final OS Results From SOLO3: Phase III Trial Assessing Olap…

SGO 2022 Conference Coverage on VuMedi

R. Penson

337 views

SGO 2022 on a Phase 2 OVARIO Study of Niraparib + Bevacizumab in Adv…

SGO 2022 Conference Coverage on VuMedi

M. Hardesty

289 views

SGO 2022 on a Randomized Phase 3 Trial of IP vs. IV Carboplatin With…

SGO 2022 Conference Coverage on VuMedi

K. Fujiwara

273 views

SGO 2022 on Clinical Outcomes of Ovarian Cancer Patients Treated Wit…

SGO 2022 Conference Coverage on VuMedi

I. Winer

247 views

SGO 2022: Recognition and Management of Side Effects Associated With…

SGO 2022 Conference Coverage on VuMedi

M. Raza Mirza

133 views

SGO 2022: Development of an Interactive Precision Medicine Dashboard…

SGO 2022 Conference Coverage on VuMedi

A. Haggerty

58 views

SGO 2022 on Shared Decision Making in Frontline Maintenance Therapy …

SGO 2022 Conference Coverage on VuMedi

A. Haggerty

214 views

SGO 2022 on Maintenance Therapy in Advanced Ovarian Cancer: Results …

SGO 2022 Conference Coverage on VuMedi

D. Chase

279 views

SGO 2022 Update on Maintenance Olaparib Rechallenge in Patients With…

SGO 2022 Conference Coverage on VuMedi

E. Pujade-Lauraine

74 views